Kurt Rasmussen

age ~67

from Fishers, IN

Get Report

Also known as:

Connected to:

Kurt Rasmussen Phones & Addresses

Compounds Having Effects On Serotonin-Related Systems
view source
US Patent:

55763219, Nov 19, 1996
Filed:

Jun 6, 1995
Appl. No.:

8/468900
Inventors:

Joseph H. Krushinski - Indianapolis IN
Kurt Rasmussen - Fishers IN
Vincent P. Rocco - Indianapolis IN
John M. Schaus - Zionsville IN
Dennis C. Thompson - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3140
C07D20910
C07D20912
C07D20914
US Classification:

514255
Abstract:

A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1. sub. A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.

Compounds Having Effects On Serotonin-Related Systems
view source
US Patent:

56271964, May 6, 1997
Filed:

Jun 6, 1995
Appl. No.:

8/468948
Inventors:

James E. Audia - Indianapolis IN
David J. Hibschman - Bargersville IN
Joseph H. Krushinski - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Jeffrey S. Nissen - Fishers IN
Kurt Rasmussen - Fishers IN
Vincent P. Rocco - Indianapolis IN
John M. Schaus - Zionsville IN
Dennis C. Thompson - Indianapolis IN
David T. Wong - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 31445
C07D40900
US Classification:

514323
Abstract:

A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1. sub. A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.

Compounds Having Effects On Serotonin-Related Systems
view source
US Patent:

56145233, Mar 25, 1997
Filed:

Jun 6, 1995
Appl. No.:

8/470512
Inventors:

James E. Audia - Indianapolis IN
Joseph H. Krushinski - Indianapolis IN
Kurt Rasmussen - Fishers IN
Vincent P. Rocco - Indianapolis IN
John M. Schaus - Zionsville IN
Dennis C. Thompson - Indianapolis IN
David T. Wong - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3150
C07D24104
US Classification:

514252
Abstract:

A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1. sub. A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.

Method For Treating Nicotine Withdrawal
view source
US Patent:

56961154, Dec 9, 1997
Filed:

Apr 21, 1995
Appl. No.:

8/422202
Inventors:

Kurt Rasmussen - Fishers IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3155
US Classification:

514220
Abstract:

The invention provides a method for treating a condition resulting from the cessation and withdrawal of nicotine comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno�2,3-b!�1,5!-benzodiazepine.

Compounds Having Effects On Serotonin-Related Systems
view source
US Patent:

57417890, Apr 21, 1998
Filed:

Jun 6, 1995
Appl. No.:

8/467434
Inventors:

David J. Hibschman - Bargersville IN
Joseph H. Krushinski - Indianapolis IN
Kurt Rasmussen - Fishers IN
Vincent P. Rocco - Indianapolis IN
John M. Schaus - Zionsville IN
Dennis C. Thompson - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D22700
C07D40112
A61K 31395
A61K 31445
US Classification:

514210
Abstract:

A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1. sub. A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.

Method For Treating Substance Abuse Withdrawal
view source
US Patent:

57327173, Mar 31, 1998
Filed:

Aug 12, 1996
Appl. No.:

8/695451
Inventors:

August M. Watanabe - Indianapolis IN
Thomas F. Bumol - Carmel IN
Mitchell I. Steinberg - Indianapolis IN
Mary J. Kallman - Greenfield IN
Kurt Rasmussen - Fishers IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61B 1900
US Classification:

128898
Abstract:

This invention provides a method for treating a condition resulting from the cessation or withdrawal of tobacco or nicotine, opioids, ethanol or combinations thereof comprising administering an effective amount of 4-chloro-5-(imidazoline-2-y(amino)-6-methoxy-2-methylpyrimidine.

Method For Treating Substance Abuse
view source
US Patent:

61599638, Dec 12, 2000
Filed:

Nov 25, 1997
Appl. No.:

8/952845
Inventors:

Charles M Beasley - Indianapolis IN
Kurt Rasmussen - Fishers IN
Gary D Tollefson - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3155
US Classification:

514220
Abstract:

The invention provides a method for treating substance abuse comprising administering an effective amount of olanzapine or pharmaceutically acceptable salt thereof to a patient in need thereof.

Compounds Having Effects On Serotonin-Related Systems
view source
US Patent:

57894027, Aug 4, 1998
Filed:

Jun 6, 1995
Appl. No.:

8/471121
Inventors:

James E. Audia - Indianapolis IN
David J. Hibschman - Bargersville IN
Joseph H. Krushinski - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Jeffrey S. Nissen - Fishers IN
Kurt Rasmussen - Fishers IN
Vincent P. Rocco - Indianapolis IN
John M. Schaus - Zionsville IN
Dennis C. Thompson - Indianapolis IN
David T. Wong - Indianapolis IN
Assignee:

Eli Lilly Company - Indianapolis IN
International Classification:

A61K 3155
C07D40500
C07D40100
C07D40900
US Classification:

514213
Abstract:

A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1. sub. A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.